Cargando…
Reduced dosing of enoxaparin for venous thromboembolism in overweight and obese adolescents: a single institution retrospective review
ESSENTIALS: Data is scarce on enoxaparin dosing for obese adolescents with venous thromboembolism (VTE). Overweight and obese adolescents treated with reduced enoxaparin dose (RD) were reviewed. Initial enoxaparin doses calculated using actual body weight may be greater than what is needed. Trials a...
Autores principales: | Hoffman, Stephanie, Braunreiter, Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058273/ https://www.ncbi.nlm.nih.gov/pubmed/30046689 http://dx.doi.org/10.1002/rth2.12032 |
Ejemplares similares
-
Overall and abdominal obesity in relation to venous thromboembolism
por: Yuan, Shuai, et al.
Publicado: (2020) -
Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022) -
Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
por: Röshammar, Daniel, et al.
Publicado: (2021) -
Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population
por: Raskob, Gary E., et al.
Publicado: (2022) -
Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)